RESUMO
Assessment of oxidative stress is an important but technically challenging procedure in medical and biological research. The reactive oxygen metabolites (d-ROMs) test is a simple assay marketed for analyzing the total amount of hydroperoxides in serum via the Fenton's reaction. Earlier reports have raised a suspicion that a part of the signal detected in the assay comes from sources other than metabolites generated by oxidative stress. The aim of this study was to identify which serum components interfere with the d-ROMs signal. By application of sodium azide, ethylenediaminetetraacetic acid, sodium dodecylsulphate, varying temperature, and spiking endogenous substances we demonstrate that in the case of mammalian sera the assay determines ceruloplasmin (CP) activity with potential interferences from hydroperoxides, iron level, thiols, and albumin. In sera of avian species hydroperoxides contribute more to the test outcome, but the CP part is insensitive to inhibition by azide. In conclusion, this assay has deficiencies in terms of detecting realistic concentrations of hydroperoxides, is mostly measuring CP and is also interfered with other serum components, making it very difficult to interpret in most biological systems.
Assuntos
Técnicas de Laboratório Clínico/instrumentação , Estresse Oxidativo/fisiologia , Espécies Reativas de Oxigênio/metabolismo , Ceruloplasmina/análise , Ceruloplasmina/metabolismo , Humanos , Reprodutibilidade dos Testes , EspectrofotometriaRESUMO
Among the markers and targets of the early phase of Alzheimer's disease (AD) pathogenesis MnSOD (mitochondrial dysfunction) and Na-pump (disturbances in function/regulation) are often highlighted. This paper focused on comparison of the effects of three antioxidants on the activity of cerebrocortical MnSOD and Na,K-ATPase from post mortem Alzheimer's disease and age-matched normal brains. Antioxidant compounds with different origins: natural glutathione, synthetic UPF peptides (glutathione analogues) and phytoestrogen genistein were investigated. Firstly, MnSOD and Na,K-ATPase activities were found to be decreased in the post mortem AD brains compared with age-matched controls. Secondly, GSH had no effect on MnSOD activity, but decreased Na,K-ATPase activity both in the control and AD brains. Thirdly, UPF1 and UPF17 increased MnSOD activity, and UPF17 suppressed Na,K-ATPase activity. Further studies are needed to clarify, if the inhibitory effect of UPF17 on Na,K-ATPase could abolish the beneficial effect gained from MnSOD activation. Both the antioxidative potential of genistein and its potency to up-regulate Na,K-ATPase activity make it an attractive candidate substance to suppress the early phase of the pathogenesis of AD.
Assuntos
Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/enzimologia , Antioxidantes/farmacologia , Lobo Frontal/efeitos dos fármacos , ATPase Trocadora de Sódio-Potássio/metabolismo , Superóxido Dismutase/metabolismo , Lobo Temporal/efeitos dos fármacos , Idoso de 80 Anos ou mais , Antioxidantes/uso terapêutico , Estudos de Casos e Controles , Lobo Frontal/enzimologia , Genisteína/uso terapêutico , Glutationa/análogos & derivados , Glutationa/farmacologia , Glutationa/uso terapêutico , Humanos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/enzimologia , Oligopeptídeos/farmacologia , Oligopeptídeos/uso terapêutico , Lobo Temporal/enzimologiaRESUMO
Milk composition has been known to change during lactation. To help understand the changes in metabolic profile throughout the whole lactation, liquid chromatography mass-spectrometry was used to analyze 306 milk samples from 82 primi- and multiparous dairy cows. Changes in metabolic profile common to all cows throughout lactation were ascertained based on principal component and general linear model analysis. Sets of specific markers; for instance, 225, 397, and 641-642 m/z (positive mode), and 186, 241, and 601-604 (negative mode), with at least a 1.5-fold higher intensity during the first 60 d compared with the last 60 d of lactation were observed. The metabolome was affected by parity and milking time. Markers, identified as peptides differentiating parity, were observed. A significant increase for citrate was observed in evening milk. Milk coagulation traits were strongly animal specific. The curd firmness values were influenced by milking time. Sets of markers were associated with curd firmness in positive (197 m/z) and negative (612, 737, 835, 836, 902, 1000, 1038, and 1079 m/z) ion mode.
Assuntos
Lactação , Leite/metabolismo , Animais , Bovinos , Feminino , Metaboloma , Leite/químicaRESUMO
Mitochondrial disorders are a heterogeneous group of disorders affecting energy production of the body. Different consensus diagnostic criteria for mitochondrial disorders in childhood are available - Wolfson, Nijmegen and modified Walker criteria. Due to the extreme complexity of mitochondrial disorders in children, we decided to develop a diagnostic algorithm, applicable in clinical practice in Estonia, in order to identify patients with mitochondrial disorders among pediatric neonatology and neurology patients. Additionally, it was aimed to evaluate the live-birth prevalence of mitochondrial disorders in childhood. During the study period (2003-2009), a total of 22 children were referred to a muscle biopsy in suspicion of mitochondrial disorder based on the preliminary biochemical, metabolic and instrumental investigations. Enzymatic and/or molecular analysis confirmed mitochondrial disease in 5 of them - an SCO2 gene (synthesis of cytochrome c oxidase, subunit 2) defect, 2 cases of pyruvate dehydrogenase complex deficiency and 2 cases of combined complex I and IV deficiency. The live-birth prevalence for mitochondrial defects observed in our cohort was 1/20,764 live births. Our epidemiological data correlate well with previously published epidemiology data on mitochondrial diseases in childhood from Sweden and Australia, but are lower than in Finland.
RESUMO
The molecular composition of milk is influenced by various genetic and environmental factors. Time is one important factor, and the fact that certain milk components change over the course of lactation is widely accepted. Untargeted global metabolomics is an approach to study hundreds of low molecular weight compounds simultaneously. In this study, mass spectrometry-based global metabolomics was used to follow the course of changes in milk (n=133) and blood plasma (n=133) during the early stage of lactation. Little correlation was found between the molecular composition of blood plasma and milk. Blood showed a higher dependence on animal individuality than did milk, in which common evolutions in time resolved. Citrate and lactose had the greatest effect on these changes; however, the most significant changes in milk during the first months of lactation were associated with phosphorylated saccharide levels, whereas the most significant changes in blood plasma were associated with levels of polyunsaturated fatty acids containing phosphatidylcholine. In conclusion, a new systemic approach was used to search for minor metabolites whose concentrations were significantly altered in milk and blood during the first months of lactation.
Assuntos
Bovinos/metabolismo , Lactação/metabolismo , Metaboloma/fisiologia , Leite/química , Animais , Bovinos/sangue , Bovinos/fisiologia , Dieta/veterinária , Metabolismo Energético/fisiologia , Feminino , Lactação/sangue , Lactação/fisiologia , Leite/metabolismo , Espectrometria de Massas em Tandem/veterinária , Fatores de TempoRESUMO
We hypothesize that, through milk composition and different milk metabolites, it is possible to characterize the technological properties (e.g., coagulation) of milk. In this research, liquid chromatography mass spectrometry was used to obtain profiles of low molecular weight organic compounds in 143 milk samples. The metabolic profiles of milk from cows were correlated with their coagulation properties. Using multivariate data analysis methods, we demonstrated that the metabolic profiles of the milk were correlated with coagulation ability. Several marker ions responsible for differential coagulation were found. Although not all affected metabolites could be identified, the most significant differences were found for carnitine and oligosaccharides. Exploitation of these results may increase the use of biomarkers to assess the coagulation ability of milk. This study represents the first large-scale metabolomic profiling of noncoagulating and coagulating bovine milk samples in Estonia.
Assuntos
Leite/metabolismo , Animais , Bovinos , Gorduras/análise , Temperatura Alta , Concentração de Íons de Hidrogênio , Metaboloma , Leite/química , Proteínas do Leite/análise , Espectrometria de Massas em TandemRESUMO
The aim of our study was to evaluate the prevalence of long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) in the general Estonian population and among patients with symptoms suggestive of fatty acid oxidation (FAO) defects. We collected DNA from a cohort of 1,040 anonymous newborn blood spot samples. We screened these samples for the presence of the common c.1528G>C mutation in the HADHA gene. Based on the clinical suspicion of FAO defects, we screened suspected individuals since 2004 for the common c.1528G>C mutation in the HADHA gene and since 2008 in addition by tandem mass spectrometric analysis of plasma acylcarnitines. Our results showed that the carrier frequency of the c.1528G>C mutation in the Estonian population is high - 1:173. During the screening of symptomatic patients, we identified five LCHADD patients in four families. Three patients were retrospectively identified by molecular screening of the HADHA gene. One patient was homozygous for the c.1528G>C mutation in the HADHA gene, and two siblings were compound heterozygotes with HADHA genotype c.[1528G>C]+[1690-2A>G]. Among patients tested using acylcarnitine profiling, we identified two cases with an abnormal acylcarnitine profile typical to LCHADD. Molecular analysis showed homozygosity for c.1528G>C mutation. Based on a carrier frequency of 1:173 (95% Confidence Interval 1:76-1:454) and taking into account that the c.1528G>C mutation makes up 87.5% of disease alleles in Estonian LCHADD patients, the estimated prevalence of LCHADD in Estonia would be 1: 91,700.
RESUMO
Communication between various ovarian cell types is a prerequisite for folliculogenesis and ovulation. In antral follicles granulosa cells divide into two distinct populations of mural and cumulus granulosa cells (CGC), enveloping the antrum and surrounding the oocyte, respectively. Both cell types, with the mural compartment in excess, contribute to the floating granulosa cell (FGC) population in the follicular fluid. The aim of this study was to compare the transcriptomes of FGC and CGC in stimulated antral follicles obtained from 19 women undergoing IVF-ICSI procedure. FGC were obtained from follicular fluid during the follicle puncture procedure and CGC were acquired after oocyte denudation for micromanipulation. Gene expression analysis was conducted using the genome-wide Affymetrix transcriptome array. The expression profile of the two granulosa cell populations varied significantly. Out of 28 869 analysed transcripts 4480 were differentially expressed (q-value < 10(-4)) and 489 showed > or =2-fold difference in the expression level with 222 genes up-regulated in FGC and 267 in CGC. The transcriptome of FGC showed higher expression of genes involved in immune response, hematological system function and organismal injury, although CGC had genes involved in protein degradation and nervous system function up-regulated. Cell-to-cell signalling and interaction pathways were noted in both cell populations. Furthermore, numerous novel transcripts that have not been previously described in follicular physiology were identified. In conclusion, our results provide a solid basis for future studies in follicular biology that will help to identify molecular markers for oocyte and embryo viability in IVF.
Assuntos
Células do Cúmulo/metabolismo , Perfilação da Expressão Gênica , Folículo Ovariano/citologia , Adulto , Células Cultivadas , Células do Cúmulo/efeitos dos fármacos , Feminino , Hormônio Foliculoestimulante/farmacologia , Hormônio Liberador de Gonadotropina/antagonistas & inibidores , Hormônios/farmacologia , Humanos , Infertilidade Feminina/metabolismo , Análise em Microsséries , Reação em Cadeia da PolimeraseRESUMO
The aim of present study was to describe changes in gene expression in the temporal lobe of mice induced by deletion of the Wfs1 gene. Temporal lobes samples were analyzed using Affymetrix Mouse Genome 420 2 GeneChips and expression profiles were functionally annotated with GSEA and Ingenuity Pathway Analysis. We found that Wfs1 mutant mice are significantly smaller (20.9 +/- 1.6 g) than their wild-type counterparts (31.0 +/- 0.6 g, P < 0.0001). This difference existed in 129S6 and C57B6 backgrounds. Interestingly, microarray analysis identified upregulation of growth hormone (GH) transcripts and functional analysis revealed activation of GH pathways. In line with microarray data, the level of IGF-1 in the plasma of Wfs1 mutant mice was significantly increased (P < 0.05). Thus, Wfs1 deletion induces growth retardation, whereas the GH pathway is activated. To test the interaction between the Wfs1 deletion and genomic background, mutant mice were backcrossed to two different genetic backgrounds. In line with previous studies, an interaction between a gene knockout and genetic background was found in gene expression profiles in the congenic region. However, genetic background did not alter the effect of the Wfs1 mutation on either body weight or GH pathway activation. Further studies are needed to describe biochemical and molecular changes of the growth hormone axis as well as in other hormones to clarify their role in growth retardation in the Wfs1 mutant mice.
Assuntos
Peso Corporal/fisiologia , Hormônio do Crescimento/fisiologia , Proteínas de Membrana/fisiologia , Transdução de Sinais/fisiologia , Animais , Peso Corporal/genética , Feminino , Perfilação da Expressão Gênica , Genótipo , Hormônio do Crescimento/genética , Fator de Crescimento Insulin-Like I/metabolismo , Masculino , Proteínas de Membrana/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos , Camundongos Knockout , Análise de Sequência com Séries de Oligonucleotídeos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transdução de Sinais/genética , Lobo Temporal/metabolismo , Lobo Temporal/fisiologiaRESUMO
Different glutathione analogues have potential to maintain or increase tissue glutathione level and to scavenge the reactive oxygen species. We designed and synthesized a novel non-toxic glutathione analogue, named UPF1, which possessed 60-fold higher hydroxyl radical scavenger efficiency in vitro, compared with glutathione itself, and investigated the effects of UPF1 on a four-vessel occlusion model of rats. The UPF1 was administered via the jugular vein in two separate experiments at two time points: 20 min before global brain ischemia and immediately before reperfusion. In both cases the number of pyramidal cells surviving in the subfield of CA1 at the dorsal hippocampus in the UPF1-treated groups of rats was twice as high as in the vehicle group.
Assuntos
Antioxidantes/uso terapêutico , Infarto Cerebral/prevenção & controle , Ataque Isquêmico Transitório/complicações , RNA Helicases/uso terapêutico , Animais , Contagem de Células , Morte Celular/efeitos dos fármacos , Infarto Cerebral/etiologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Glutationa/farmacologia , Hipocampo/efeitos dos fármacos , Hipocampo/patologia , Masculino , Ratos , Ratos Wistar , Traumatismo por Reperfusão/prevenção & controle , Fatores de TempoRESUMO
The activation of nuclear factor kappaB (NFkappaB) is a key event in immune and inflammatory responses. In this study, a cell-penetrating transport peptide, transportan (TP) or its shorter analogue TP 10, was used to facilitate the cellular uptake of an NFkappaB decoy. Peptide nucleic acid (PNA) hexamer or nonamer was linked to the transport peptide by a disulfide bond. NFkappaB decoy oligonucleotide consisted of a double-stranded consensus sequence corresponding to the kappaB site localized in the IL-6 gene promoter, 5'-GGGACTTTCCC-3', with a single-stranded protruding 3'-terminal sequence complementary to the PNA sequence was hybridized to the transport peptide-PNA construct. The ability of the transport peptide-PNA-NFkappaB decoy complex to block the effect of interleukin (IL)-1beta-induced NFkappaB activation and IL-6 gene expression was analyzed by electrophoretic mobility shift assay and reverse transcriptase-polymerase chain reaction in rat Rinm5F insulinoma cells. Preincubation with transport peptide-PNA-NFkappaB decoy (1 microM, 1 h) blocked IL-1beta-induced NFkappaB-binding activity and significantly reduced the IL-6 mRNA expression. The same concentration of NFkappaB decoy in the absence of transport peptide-PNA had no effect even after longer incubations. Our results showed that binding of the oligonucleotide NFkappaB decoy to the nonamer PNA sequence resulted in a stable complex that was efficiently translocated across the plasma membrane.
Assuntos
Oligodesoxirribonucleotídeos/genética , Oligonucleotídeos/genética , Ácidos Nucleicos Peptídicos/genética , Proteínas Recombinantes de Fusão/genética , Animais , Sequência de Bases , Portadores de Fármacos , Ensaio de Desvio de Mobilidade Eletroforética/métodos , Galanina , Expressão Gênica , Interleucina-1/genética , Interleucina-6/genética , Modelos Genéticos , Hibridização de Ácido Nucleico/genética , RNA Mensageiro/genética , Ratos , Venenos de VespasRESUMO
In the frontal cortex (FC) of the normally aging human brain, glutathione (GSH) and its novel analogue, UPF1, stimulate G proteins more than in Alzheimer's disease (AD) FC. In normal aging and in AD, UPF1 is a more efficient stimulator of G proteins than GSH. In normal FC, both GSH and UPF1 stimulate G proteins, which mediate inhibitory signals to the cAMP system; while in AD, only UPF1 exhibits the same action. Stimulation of G proteins and coupled signaling by GSH antioxidant analogues, as potential signaling molecules, may ameliorate the oxidative impairments of neuronal signaling in AD.
Assuntos
Envelhecimento/fisiologia , Doença de Alzheimer/metabolismo , Lobo Frontal/metabolismo , Proteínas de Ligação ao GTP/metabolismo , Glutationa/análogos & derivados , Glutationa/farmacologia , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Adenilil Ciclases/metabolismo , Idoso , Idoso de 80 Anos ou mais , Membrana Celular/metabolismo , AMP Cíclico/metabolismo , Lobo Frontal/efeitos dos fármacos , Humanos , Cinética , Valores de ReferênciaRESUMO
Peptide nucleic acids (PNA) are nucleic acid analogues containing neutral amide backbone, forming stable and tight complexes with complementary DNA/RNA. However, it is unclear whether unmodified PNA can efficiently penetrate neuronal tissue in order to act as antisense reagent. Here we show that intrathecal (i.t.) injection of an unmodified antisense PNA complementary to the rat galanin receptor type 1 (GalR1) mRNA is able to block the inhibitory effect of i.t. administered galanin on spinal nociceptive transmission. Autoradiographic ligand binding studies using [125I]galanin show that the unmodified PNA is able to reduce the density of galanin binding sites in the dorsal horn. Thus, unmodified PNA applied i.t. appears to function as an effective antisense reagent in rat spinal cord in vivo.
Assuntos
Galanina/farmacologia , Ácidos Nucleicos Peptídicos/farmacologia , Receptores de Neuropeptídeos/genética , Receptores de Neuropeptídeos/metabolismo , Medula Espinal/metabolismo , Animais , Autorradiografia , Sistemas de Liberação de Medicamentos , Eletrofisiologia , Feminino , Injeções Espinhais , Radioisótopos do Iodo , Ligantes , Fibras Nervosas/efeitos dos fármacos , Fibras Nervosas/metabolismo , Neurônios Aferentes/efeitos dos fármacos , Neurônios Aferentes/metabolismo , Nociceptores/efeitos dos fármacos , Nociceptores/metabolismo , Oligonucleotídeos Antissenso/farmacologia , Ratos , Ratos Sprague-Dawley , Receptor Tipo 1 de Galanina , Receptores de Galanina , Medula Espinal/citologia , Medula Espinal/efeitos dos fármacosRESUMO
Novel analogues of the cell-penetrating peptides penetratin and transportan were synthesized. The distribution of the biotin-labeled peptides in Bowes melanoma cell line has been investigated by indirect fluorescence with fluorescein-streptavidin detection. The time course of uptake of (125)I-labeled transportan analogues has been characterized in the same cell line. Molecular modeling was used to analyze the penetration and the orientation of molecules in a simulated biological membrane. The results, both from molecular modeling and fluorescence studies, imply that penetratin and transportan do not enter the cells by related mechanisms and that they do not belong to the same family of translocating peptides.
Assuntos
Proteínas de Transporte/síntese química , Portadores de Fármacos , Peptídeos/síntese química , Peptídeos/farmacocinética , Proteínas Recombinantes de Fusão/síntese química , Sequência de Aminoácidos , Proteínas de Transporte/metabolismo , Membrana Celular/metabolismo , Peptídeos Penetradores de Células , Galanina , Humanos , Melanoma , Modelos Moleculares , Dados de Sequência Molecular , Peptídeos/química , Conformação Proteica , Proteínas Recombinantes de Fusão/farmacocinética , Células Tumorais Cultivadas , Venenos de VespasRESUMO
Several shorter analogues of the cell penetrating peptide, transportan, have been synthesized in order to define the regions of the sequence, which are responsible for the membrane translocation property of the peptide. Penetration of the peptides into Bowes melanoma cells and the influence on GTPase activity in Rin m5F cellular membranes have been tested. The experimental data on cell penetration have been compared with molecular modeling of insertion of peptides into biological membranes. Omission of six amino acids from the N-terminus did not significantly impair the cell penetration of the peptide while deletions at the C-terminus or in the middle of the transportan sequence decreased or abolished the cellular uptake. Most transportan analogues exert an inhibitory effect on GTPase activity. Molecular modeling shows that insertion of the transportan analogues into the membrane differs for different peptides. Probably the length of the peptide as well as the location of aromatic and positively charged residues have major impact on the orientation of peptides in the membranes and thereby influence the cellular penetration. In summary, we have designed and characterized several novel short transportan analogues with similar cellular translocation properties to the parent peptide, but with reduced undesired cellular activity.
Assuntos
Membrana Celular/química , Fosfolipídeos/química , Proteínas Recombinantes de Fusão/química , Álcoois , Sequência de Aminoácidos , Permeabilidade da Membrana Celular , Desenho de Fármacos , GTP Fosfo-Hidrolases/química , Galanina , Humanos , Radioisótopos do Iodo , Bicamadas Lipídicas/química , Modelos Moleculares , Dados de Sequência Molecular , Alinhamento de Sequência , Células Tumorais Cultivadas , Venenos de Vespas , ÁguaRESUMO
To determine the domains essential for G-protein coupling of the human galanin receptor type 1 (GalR1), we have used both GalR1 mutants and synthetic receptor-derived peptides in(125)I-galanin and [(35)S]-GTPgammaS binding studies. Replacement of potential phosphorylation sites by Leu in the third intracellular loop (IC3) of GalR1 did not affect K(D)values for the receptor. Peptides derived form the IC3 loop, and especially the N-terminal part of it were able to increase the rate of [(35)S]-GTPgammaS binding to the trimeric Gialpha1beta1gamma2, but not to Gsalphabeta1gamma2, whereas the peptides corresponding to the IC1 and IC2 loops had no such effect. IC3 loop peptides also inhibited the binding of(125)I-galanin to GalR1 in membranes from Rin m5F cells. Our results suggest that the IC3 loop of GalR1, especially its N-terminal part, defines the coupling of the receptor to the Gialpha1beta1gamma2 protein and consequently, to the signal transduction cascade.
Assuntos
Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Receptores de Neuropeptídeos/química , Receptores de Neuropeptídeos/metabolismo , Transdução de Sinais/fisiologia , Sequência de Aminoácidos , Substituição de Aminoácidos , Animais , Sítios de Ligação , Linhagem Celular , Membrana Celular/metabolismo , Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP/metabolismo , Subunidades alfa Gs de Proteínas de Ligação ao GTP/metabolismo , Galanina/metabolismo , Humanos , Cinética , Leucina , Modelos Moleculares , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/farmacologia , Fosforilação , Estrutura Secundária de Proteína , Receptor Tipo 1 de Galanina , Receptores de Galanina , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Spodoptera , TransfecçãoRESUMO
The effects of the 29-amino acid neuropeptide galanin [GAL (1-29)], GAL(1-15), GAL(1-16), and the GAL subtype 2 receptor agonist D-tryptophan(2)-GAL(1-29) were studied in the dorsal hippocampus in vitro with intracellular recording techniques. GAL(1-15) induced, in the presence of tetrodotoxin, a dose-dependent hyperpolarization in hippocampal CA3 neurons. Most of the GAL(1-15)-sensitive neurons did not respond to GAL(1-29), GAL(1-16), or D-tryptophan(2)-GAL(1-29). These results indicate the presence of a distinct, yet-to-be cloned GAL(1-15)-selective receptor on CA3 neurons in the dorsal hippocampus.
Assuntos
Galanina/farmacologia , Hipocampo/efeitos dos fármacos , Fragmentos de Peptídeos/farmacologia , Receptores de Neuropeptídeos/análise , Animais , Hipocampo/química , Hipocampo/fisiologia , Masculino , Potenciais da Membrana/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Receptores de GalaninaRESUMO
PNA is a nucleic acid analog with an achiral polyamide backbone consisting of N-(2-aminoethyl)glycine units (figure 1). The purine or pyrimidine bases are linked to the each unit via a methylene carbonyl linker (1-3) to target the complementary nucleic acid (4). PNA binds to complementary RNA or DNA in a parallel or antiparallel orientation following the Watson-Crick base-pairing rules (5-7). The uncharged nature of the PNA oligomers enhances the stability of the hybrid PNA/DNA(RNA) duplexes as compared to the natural homoduplexes. The non-natural character of the PNA makes PNA oligomers highly resistant to protease and nuclease attacks (8). These properties of PNA oligomers suggest that they could potentially serve as efficient antisense or antigene reagents. Indeed, peptide nucleic acids have been applied to block protein expression on the transcriptional (9) and translational level (10,11), and microinjected PNA oligomers demonstrate a strong antisense effect in intact cells (12). However, contrary to the "normal" nucleic acid analogs, PNA oligomers are not efficiently delivered into the cytoplasm of the cell, and until recently this has hindered the application of PNA oligomers as antisense reagents. In this work we summarize some recent achievements on PNA antisense application, especially these concerned with whole cell or tissue delivery of the PNA.
Assuntos
DNA Antissenso/uso terapêutico , Terapia Genética/métodos , Ácidos Nucleicos Peptídicos/farmacocinética , Ácidos Nucleicos Peptídicos/uso terapêutico , Animais , Proteínas de Transporte/farmacocinética , DNA Antissenso/farmacocinética , Lipossomos/farmacocinéticaRESUMO
Two chimeric peptides, consisting of the linear vasopressin receptor V1 antagonist PhAc-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr, in the N-terminus and mastoparan in the C-terminus connected directly (M375) or via 6-aminohexanoic acid (M391), have been synthesised. At 10 microM concentration, these novel peptides increased insulin secretion from isolated rat pancreatic islet cells 18-26-fold at 3.3 mM glucose and 3.5-5-fold at 16.7 mM glucose. PTX pretreatment of the islets decreased the peptide-induced insulin release. M375 and M391 bind to V1a vasopressin receptors with affinities lower than the unmodified vasopressin antagonist, but with K(D) values of 3.76 nM and 9.02 nM, respectively, both chimeras are high affinity ligands. The GTPase activity and GTPgammaS binding in the presence of these peptides has been characterised in Rin m5F cells. Comparison of the influence of the peptides M375 and M391 on GTPase activity in native and pertussis toxin-treated cells suggests a selective activation of G alpha(i)/G alpha(o) subunits, combined with a suppression of other GTPases, primarily G alpha(s). However, the GTPgammaS binding data show that the peptides retain some of the activating property even in PTX-treated cell membranes. In conclusion, the conjugation of mastoparan with the V1a receptor antagonists produce peptides with properties different from the parent peptides that could be used to elucidate the role of different G proteins in insulin release.
Assuntos
Antagonistas dos Receptores de Hormônios Antidiuréticos , Proteínas de Ligação ao GTP/metabolismo , Insulina/metabolismo , Proteínas Recombinantes de Fusão/farmacologia , Venenos de Vespas/farmacologia , Animais , Membrana Celular/metabolismo , GTP Fosfo-Hidrolases/efeitos dos fármacos , GTP Fosfo-Hidrolases/metabolismo , Proteínas de Ligação ao GTP/efeitos dos fármacos , Glucose/farmacologia , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Técnicas In Vitro , Peptídeos e Proteínas de Sinalização Intercelular , Ilhotas Pancreáticas/efeitos dos fármacos , Ilhotas Pancreáticas/metabolismo , Masculino , Peptídeos/síntese química , Peptídeos/metabolismo , Peptídeos/farmacologia , Toxina Pertussis , Ligação Proteica , Ratos , Ratos Wistar , Receptores de Vasopressinas/metabolismo , Células Tumorais Cultivadas/efeitos dos fármacos , Vasopressinas/metabolismo , Vasopressinas/farmacologia , Fatores de Virulência de Bordetella/farmacologia , Venenos de Vespas/metabolismoRESUMO
Modulation of GTPase and adenylate cyclase (ATP pyrophosphate-lyase, EC 4.6.1.1) activity by Alzheimer's disease related amyloid beta-peptide, A beta (1-42), and its shorter fragments, A beta (12-28), A beta (25-35), were studied in isolated membranes from rat ventral hippocampus and frontal cortex. In both tissues, the activity of GTPase and adenylate cyclase was upregulated by A beta (25-35), whereas A beta (12-28) did not have any significant effect on the GTPase activity and only weakly influenced adenylate cyclase. A beta (1-42), similar to A beta (25-35), stimulated the GTPase activity in both tissues and adenylate cyclase activity in ventral hippocampal membranes. Surprisingly, A beta (1-42) did not have a significant effect on adenylate cyclase activity in the cortical membranes. At high concentrations of A beta (25-35) and A beta (1-42), decreased or no activation of adenylate cyclase was observed. The activation of GTPase at high concentrations of A beta (25-35) was pertussis toxin sensitive, suggesting that this effect is mediated by Gi/G(o) proteins. Addition of glutathione and N-acetyl-L-cysteine, two well-known antioxidants, at 1.5 and 0.5 mM, respectively, decreased A beta (25-35) stimulated adenylate cyclase activity in both tissues. Lys-A beta (16-20), a hexapeptide shown previously to bind to the same sequence in A beta-peptide, and prevent fibril formation, decreased stimulation of adenylate cyclase activity by A beta (25-35), however, NMR diffusion measurements with the two peptides showed that this effect was not due to interactions between the two and that A beta (25-35) was active in a monomeric form. Our data strongly suggest that A beta and its fragments may affect G-protein coupled signal transduction systems, although the mechanism of this interaction is not fully understood.